New York, December 19, 2023 – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its Investigational New Drug Application (IND) for NRX-101 for the treatment of
NEW YORK, NY, December 18, 2023 – Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in generalized
NEW YORK, NY, December 18, 2023 – Shares in Battalion Oil Corporation (NYSE American: BATL) surged more than 80% on Friday after the company announced it has agreed
In the fast-paced landscape of experiential design and technology, Creative Realities Inc. seamlessly integrates the physical and digital realms in creating immersive experiences that captivate
SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023, under the symbol “SING” Simultaneous capital raise of $4 Million
Correcting number of shares in previous Press Release SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023, under the
NEW YORK, NY, December 15, 2023 – NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has reported additional positive efficacy data from its Phase 2b trial evaluating PrimeC, the company’s lead drug candidate
Transaction will provide Formation Minerals Inc., a wholly-owned subsidiary of SensaSure Technologies, Inc. (OTCQB: SSTC) the ability to be one of the first end to
Phoenix, AZ, December 15, 2023 – SinglePoint Inc. formerly (OTC: SING) now trades as (Cboe: SING) (“SinglePoint” or the “Company”), a diversified holding company principally engaged
NEW YORK, NY, December 14, 2023 – In the fast-paced landscape of experiential design and technology, Creative Realities Inc. ($CREX) seamlessly integrates the physical and
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
